Jump to content

Draft:Suraksha Pharma

From Wikipedia, the free encyclopedia
  • Comment: Part or all of this submission appears to be written by a Large language model (LMM) "AI Chatbot". Please do not submit such content as they very often contain outright fabrications, complete with fictitious references. They may be biased, may libel living people, or may violate copyrights. All text generated by LLMs should be verified by editors, and and sources checked, before use in articles. KylieTastic (talk) 11:30, 23 June 2025 (UTC)

Suraksha Pharma Private Limited
Company typePrivate
IndustryPharmaceuticals
FoundedMay 8, 1998 (1998-05-08)
Key people
  • Nageswararao Gupta Manepalli (Managing Director)
  • Someswara Rao Manepalli (Whole-time Director)
Products
  • Pharmaceutical formulations
  • Nutraceuticals
  • Cosmetics
Websitesurakshapharma.com

Suraksha Pharma Private Limited is an Indian pharmaceutical manufacturing company headquartered in Hyderabad, Telangana, India.[1] The company was established on 8 May 1998 and is involved in the development, manufacturing, and distribution of pharmaceutical formulations, nutraceuticals, and cosmetics.[2]

History

[edit]

Suraksha Pharma was incorporated on 8 May 1998 under the Companies Act, 1956.[3] It is registered with the Registrar of Companies (ROC), Hyderabad, and holds the Corporate Identification Number (CIN) U24230TG1998PTC029377.[4]

Management

[edit]

The company is managed by a board of directors:

  • Nageswararao Gupta Manepalli – Managing Director (since 2003)[5]
  • Someswara Rao Manepalli – Whole-time Director (since 2006)[6]
  • Padmaja Rani Manepalli – Whole-time Director (since 2016)[6]
  • Raghva Tayaru Aswani Manepalli – Whole-time Director (since 2019)[6]

Financials

[edit]

Suraksha Pharma has an authorized capital of ₹10 crore and a paid-up capital of ₹6.05 crore.[1] For the financial year ending March 2023, the company reported operating revenue between ₹1 crore and ₹100 crore, with an EBITDA growth of 35.76% year-on-year.[7]

Products and Services

[edit]

Therapeutic Categories

[edit]

Suraksha Pharma manufactures a wide range of formulations across therapeutic areas:[8]

  • Anti-ulcer medications
  • Analgesics and antipyretics
  • Antibiotics and anti-infectives
  • Neuropsychiatric medicines
  • Anti-allergic drugs
  • Cardiac care products
  • Diabetic medications
  • Nutraceuticals and antioxidants

Brands and Dosage Forms

[edit]

The company markets over 50 brands, including Amsha, Arol, Dutix, and Gliprip. Products are available in:

  • Tablets
  • Capsules
  • Dry syrups
  • External preparations

Manufacturing

[edit]

Suraksha Pharma's main manufacturing unit is located in Hyderabad.[9] It also operates a research and analytical laboratory in Roorkee, Uttarakhand.[10] The Roorkee facility is 20,000 square feet in size and is GLP compliant, Schedule-M certified, and working towards WHO-cGMP certification.

Production Capacity

[edit]
  • Tablets: 30 million units/month
  • Capsules: 10 million units/month
  • Dry syrups: 50,000 bottles/month[11]

Certifications

[edit]

The company holds the following certifications:[12]

  • ISO certification
  • GMP certification
  • FSSAI license
  • Form-26 license
  • NHP Canada approval

Exports

[edit]

Suraksha Pharma exports to more than 30 countries across Asia, Africa, North America, and the CIS region.[13] It has completed over 1,800 international shipments to 48 buyers.

Key Export Markets

[edit]
  • Canada
  • Kenya
  • Myanmar
  • United States

Exports are mainly classified under:

  • HSN Code 3004 – Medicaments in finished form
  • HSN Code 3003 – Bulk medicaments

Group Companies

[edit]

Suraksha Pharma is part of the Suraksha Group, which includes:[14]

  • MMC Health Care Limited
  • Surax Healthcare Private Limited
  • Surax Cosmetics Private Limited
  • Hemp Tribe Private Limited
  • Scoat Pharma Private Limited
  • Sumages Pharma Private Limited
  • Roorkee Research & Analytical Labs Private Limited

It also operates international subsidiaries such as Suraksha Natural Inc, Suraksha Pharma Inc, and Surax Healthcare Inc in the United States.[1]

Contract Manufacturing

[edit]

The company provides:

  • Solid and non-sterile dosage forms
  • Packaging solutions
  • Regulatory assistance[15]

It has over 60 contract manufacturing clients and an in-house foil manufacturing facility.[11]

Awards and Recognition

[edit]

Suraksha Pharma and its leadership have received several awards:[12]

  • Best Entrepreneur Award
  • Women Glory Award
  • Hall of Fame Award
  • Power Women Award
  • Women Entrepreneur Award

Future Plans

[edit]

Suraksha Pharma is pursuing WHO-cGMP certification for its R\&D facility and aims to expand into parenteral (injectable) manufacturing.[10] The company reports an annual growth rate of 60% and is focused on expanding its global footprint and developing complex formulations.

References

[edit]

Category:Pharmaceutical companies of India Category:Companies based in Hyderabad, India Category:Indian companies established in 1998 Category:Health care companies established in 1998